公众号 / 文章复苏、休克与脓毒症重症综合管理与镇静镇痛心脑血管急症

2020年重症监护药物治疗文献中的重要出版物

Major Publications in the Critical Care Pharmacotherapy Literature: 2020.
PubMed 文献 · Crit Care Explor · 2021-12-09
一句话结论本文总结2020年重症药物治疗领域1A级证据的2篇荟萃分析与5项原创试验,涉及脓毒症、镇静、心脏手术、COVID-19和卒中。

临床药学与药理学药物治疗文献更新组按月筛查36种期刊,2020年共审阅119篇文献,按GRADE标准筛选出1A级文章进行总结。本文汇总了2篇荟萃分析(去甲肾上腺素启动时机对脓毒性休克的影响、皮质类固醇在SARS-CoV-2中的应用)和5项原创试验(维生素C+氢化可的松+硫胺素对比氢化可的松治疗脓毒症、非镇静策略、右美托咪定在心脏手术中的应用、瑞德西韦治疗SARS-CoV-2、急性缺血性卒中取栓术)。

要点

  • 文献筛选方法:临床药学与药理学药物治疗文献更新组按月筛查36种期刊,2020年共审阅119篇文献,经共识选出与临床实践相关的1A级文章。
  • 纳入2篇荟萃分析:去甲肾上腺素启动时机对脓毒性休克患者的影响、皮质类固醇在SARS-CoV-2中的应用。
  • 纳入5项原创试验:维生素C+氢化可的松+硫胺素对比氢化可的松治疗脓毒症、非镇静策略、心脏手术中使用右美托咪定、瑞德西韦治疗SARS-CoV-2、急性缺血性卒中取栓术。

研究设计与关键结果

  • 本文为临床综述,总结2020年重症药物治疗领域重要文献;文献更新组按月筛查36种期刊,2020年共审阅119篇文献,按GRADE标准选出1A级文章进行总结。
  • 共总结2篇荟萃分析和5项原创研究试验,涉及脓毒症、非镇静策略、心脏手术、SARS-CoV-2和急性缺血性卒中。

证据类型、等级与局限

  • 证据类型:临床综述,纳入文献按GRADE标准筛选,仅纳入1A级文章。
  • 局限:原文未报告局限性

指南或共识出处

  • Crit Care Explor

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「适用人群与场景」「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「对床旁实践的改变」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: To summarize selected meta-analyses and trials related to critical care pharmacotherapy published in 2020.

DATA SOURCES: The Clinical Pharmacy and Pharmacology Pharmacotherapy Literature Update group screened 36 journals monthly for impactful publications.

STUDY SELECTION: The group reviewed a total of 119 articles during 2020 according to relevance for practice.

DATA EXTRACTION: Articles were selected with consensus and importance to clinical practice from those included in the monthly Clinical Pharmacy and Pharmacology Pharmacotherapy Literature Update. The group reviewed articles according to Grading of Recommendations, Assessment, Development, and Evaluations criteria. Articles with a 1A grade were selected.

DATA SYNTHESIS: Several trials were summarized, including two meta-analyses and five original research trials. Original research trials evaluating vitamin C, hydrocortisone, and thiamine versus hydrocortisone in sepsis, the use of nonsedation strategies, dexmedetomidine in cardiac surgery, remdesivir for severe acute respiratory syndrome coronavirus 2, and thrombectomy in acute ischemic stroke. Two meta-analyses determining the impact of norepinephrine initiation in patients with septic shock and the use of corticosteroids in severe acute respiratory syndrome coronavirus 2 was included.

CONCLUSIONS: This clinical review provides summary and perspectives of clinical practice impact on influential critical care pharmacotherapy publications in 2020.

来源:Crit Care Explor,查看原文。版权归原作者所有。

参考来源

  1. Bissell BD, Campbell J, Collins R, et al. Major Publications in the Critical Care Pharmacotherapy Literature: 2020. Crit Care Explor. 2021. PMID: 34909697. doi:10.1097/CCE.0000000000000590

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。